Factors controlling T-cell migration across rat cerebral endothelium in vitro

J Neuroimmunol. 1997 May;75(1-2):84-94. doi: 10.1016/s0165-5728(97)00006-4.

Abstract

The migration of lymphocytes through primary cultures of rat brain microvascular endothelial cell monolayers was examined in vitro by time-lapse videomicroscopy. Antigen-specific T cell line migration was dependent on the duration of culture (post-antigen stimulation) with exogenous interleukin-2 (IL-2). Peak migration (approximately 50% of T-cells during the 4 h migration assay) occurred after 4 days of culture with IL-2 but did not coincide with maximal expression of LFA-1, VLA-4 or the IL-2 receptor. On unstimulated endothelia antibody blockade of LFA-1 or ICAM-1 inhibited T-cell line migration to 8.0% and 6.8% of control values, respectively, whereas blocking VLA-4 and VCAM-1 had no effect. On IL-beta activated endothelium blocking LFA-1 and ICAM-1 was less effective (24.9% and 27.3% of control values, respectively) and blockade of VLA-4 and VCAM-1 brought about a reduction to 63.0% and 68.3% of controls respectively. Inhibition of IL-2-dependent proliferation with an IL-2 receptor blocking antibody also significantly inhibited T-cell migration to 22.2% of controls. Peripheral lymph node (PLN) lymphocytes could also be induced to migrate through untreated cerebral endothelial cell monolayers by cross-linking CD3 which was also time and IL-2-dependent with maximal migration (22.7%) occurring after three days in the presence of exogenous IL-2. Blocking LFA-or ICAM-1 resulted in a significant reduction in migration across IL-1 beta-activated endothelial cells to 17.4% and 20.9% of control values respectively although blocking the VLA-4/VCAM-1 interaction had no significant effect. Activation of PLN lymphocytes with concanavalin A for up to 5 days did not induce migration but when left in contact with the endothelial monolayer for 24 h migration reached 31.0%. These studies indicate that T-cells require a combination of signals to trigger the migratory phenotype which is necessary to enable them to penetrate the blood-brain barrier.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / cytology*
  • CD3 Complex / immunology
  • Cell Movement / drug effects
  • Cells, Cultured
  • Endothelium / cytology
  • Female
  • Integrin alpha4beta1
  • Integrins / immunology
  • Integrins / physiology
  • Intercellular Adhesion Molecule-1 / physiology
  • Interleukin-2 / pharmacology
  • Lymphocyte Function-Associated Antigen-1 / immunology
  • Lymphocyte Function-Associated Antigen-1 / physiology
  • Rats
  • Rats, Inbred Lew
  • Receptors, Interleukin-2 / metabolism
  • Receptors, Lymphocyte Homing / immunology
  • Receptors, Lymphocyte Homing / physiology
  • T-Lymphocytes / physiology*
  • Vascular Cell Adhesion Molecule-1 / physiology

Substances

  • CD3 Complex
  • Integrin alpha4beta1
  • Integrins
  • Interleukin-2
  • Lymphocyte Function-Associated Antigen-1
  • Receptors, Interleukin-2
  • Receptors, Lymphocyte Homing
  • Vascular Cell Adhesion Molecule-1
  • Intercellular Adhesion Molecule-1